GlycoMimetics Balance Sheet - Annual (NASDAQ:GLYC)

Add to My Stocks
$14.18 $0.28 (1.94%) GLYC stock closing price Sep 21, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at GlycoMimetics balance sheet. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our GlycoMimetics stock analysis. A company releases its balance sheet every year along with its annual results. GlycoMimetics balance sheet indicates an asset turnover ratio of 0 and debt to equity ratio of 0. Also check GlycoMimetics revenue and GlycoMimetics operating cash flow for the same period.

View latest 10 year balance sheet data to check GlycoMimetics financial performance.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
Marketable Securities-------
Raw Materials-------
Work In Progress-------
Finished Goods-------
Notes Receivable-------
Other Current Assets3.29M---2.57M--
Total Current Assets
Property Plant & Equipment2.41M2.11M1.42M1.35M1.15M1.24M-
Accumulated Depreciation1.3M1.05M-----
Net Property Plant & Equipment
Investment & Advances-------
Other Non-Current Assets-------
Deferred Charges-------
Deposits & Other Assets-------
Total Assets
Notes Payable-------
Accounts Payable2.64M1.56M--1.14M--
Current Portion Long-Term Debt-------
Current Portion Capital Leases-------
Accrued Expenses3.56M3.26M6.14M4.73M---
Income Taxes Payable-------
Other Current Liabilities1.96M1.5M1.03M--4.42M15.29M
Total Current Liabilities
Deferred Taxes/Income------4.04M
Convertible Debt-------
Long-Term Debt-------
Non-Current Capital Leases-------
Other Long-Term Liabilities-------
Total Liabilities
Minority Interest-------
Preferred Stock-------
Common Stock Net-------
Capital Surplus271.94M154.25M127.61M125.18M66.15M65.16M64.75M
Retained Earnings-152.27M-118.97M-87.16M-74.39M-63.27M-52.66M-56.32M
Treasury Stock-------
Other Liabilities-------
Shareholders Equity119.7M35.3M40.47M50.8M2.9M12.52M8.45M
Total Liabilities & Shareholders Equity128.58M42.38M48.46M57.26M5.28M18.41M28.9M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Most investors just check the GlycoMimetics stock price, and GlycoMimetics historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the GlycoMimetics PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: An asset is a resource that a corporation like GlycoMimetics owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for GLYC stock as of 2017 is $128.58M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. GLYC stock had total liabilities of $8.88M for the year 2017.

GlycoMimetics Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover